These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1526093)

  • 1. [The efficacy of i.v. immunoglobulins at high doses in a case of thrombocytopenia with an immune pathogenesis in chronic lymphocytic leukemia].
    Fiorentino E; Coppotelli L; Pergolini M; Carlizzi G; Basili S; Spanò G; Cordova C
    Clin Ter; 1992 Jan; 140(1):17-23. PubMed ID: 1526093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
    Telek B; Batár P; Uvardy M
    Orv Hetil; 2005 Aug; 146(34):1791-3. PubMed ID: 16184881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive neonatal thrombocytopenia. A case study of factors predicting the response to i.v. IgG therapy.
    Katikaneni LD; Rao KP; Lazarchick J
    Ann Clin Lab Sci; 1989; 19(4):255-9. PubMed ID: 2757353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombocyte antibodies in the serum and on the surface of the thrombocytes in patients with chronic lymphoproliferative diseases].
    Kuznetsov AI; Idel'son LI; Ivanov AL; Mazurov AV
    Ter Arkh; 1991; 63(7):26-30. PubMed ID: 1788801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis and management of immune thrombocytopenia].
    Fujimura K
    Rinsho Ketsueki; 2014 Jan; 55(1):83-92. PubMed ID: 24492041
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanisms of immune modulation in immune thrombocytopenia].
    Wahn V
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():81-5; discussion 86. PubMed ID: 8499756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet associated immunoglobulin in the pathogenesis of thrombocytopenia in patients with chronic liver disease].
    Jiang XH; Xie YT; Tan DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):566-8. PubMed ID: 16137048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.
    Molica S; Alberti A
    Haematologica; 1990; 75(1):75-8. PubMed ID: 2338291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrauterine transfusion in fetal alloimmunothrombocytopenia: comparison of maternal and fetal weight-adjusted IgG therapy with exclusive fetal thrombocyte transfusion].
    Giers G; Kroll H; Hoch J; Bald R; Bauer H; Kiefel V; Hansmann M; Hanfland P; Mueller-Eckhardt C; Scharf RE
    Beitr Infusionsther Transfusionsmed; 1997; 34():276-80. PubMed ID: 9417349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune thrombocytopenia in chronic liver disease].
    Panasiuk A; Zak J
    Pol Merkur Lekarski; 2001 Dec; 11(66):487-90. PubMed ID: 11899844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The therapeutic procedure in autoimmune thrombocytopenia in relation to the immunoglobulin specificity of the antithrombocytic autoantibodies].
    Tishchenko LM
    Vrach Delo; 1990 Jul; (7):82-6. PubMed ID: 2238609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL).
    De Rossi G; Granati L; Girelli G; Gandolfo G; Arista MC; Martelli M; Conti L; Marini R; La Tagliata R; Leone R
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):403-6. PubMed ID: 3222151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute thrombocytopenia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatment.
    Nascimbene A; Iannacone M; Brando B; De Gasperi A
    J Hepatol; 2007 Nov; 47(5):651-7. PubMed ID: 17716776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory immune thrombocytopenia after heart transplantation: a case report.
    Dhar SC; Miller LW
    J Heart Lung Transplant; 1995; 14(4):785-7. PubMed ID: 7578190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Other immune thrombocytopenias.
    Liebman H
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S24-34. PubMed ID: 18096469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS; Badakere SS
    J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of antiplatelet antibodies on the surface of platelets by direct radioimmune method in patients with different types of immune thrombocytopenia].
    Kuznetsov AI; Idel'son LI; Mazurov AV
    Biull Eksp Biol Med; 1991 Jun; 111(6):641-4. PubMed ID: 1893196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a.
    Boehlen F; Kaplan C; de Moerloose P
    Vox Sang; 1998; 74(3):201-4. PubMed ID: 9595650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.